LogiPharma 2020

21 - 23 April, 2020

Nice Acropolis | Nice, France

Conference Day Three- Thursday 23 April 2020


8:15 am - 8:50 am Welcome coffee

IGNITING YOUR SUPPLY CHAIN OF THE FUTURE

8:50 am - 9:00 am Chairman’s opening address

9:00 am - 9:20 am KEYNOTE CASE STUDY – How to ensure customer-centricity lies at the heart of your global supply chain strategy

  • Why should customer centricity be at the top of the agenda for every pharma producer in the industry?
  • What key strategic shifts are taking place at a major producer in order to assure this customer centricity?
  • Case study of how a leading pharmaceutical producer has ensured significantly greater customer service through a process of segmentation
  • What will future product portfolios demand and new technologies enable around the development of customer-centric operations?
Eric Drapé, EVP Global Operations at TEVA

Eric Drapé

EVP Global Operations
TEVA

9:20 am - 9:40 am KEYNOTE CASE STUDY - The Connected Channel: How to use blockchain to integrate with partners and achieve true optimised end to end supply chains

  • Case study of the world’s first commercial scale blockchain implementation in pharma supply chain
  • How is the technology being used to implement far more effective traceability in the end to end supply chain
  • What is required in order to effectively scale up from the pilot projects and clinical trials scale implementation?
  • What are the benefits of pan industry producer alliances for the adoption of the technology? 
Paolo Migliari, Exec. Director Supply Excellence at MSD

Paolo Migliari

Exec. Director Supply Excellence
MSD

David Ruiz, Global Demand and Customer Integration Lead at MSD

David Ruiz

Global Demand and Customer Integration Lead
MSD

9:40 am - 10:20 am PANEL DISCUSSION- How can you best collaborate to aggregate volume, drive economies of scale and enable significant developments in sea freight operations?

  • What are the largest barriers for the adoption of sea freight in pharmaceutical logistics?
  • What are key stakeholders doing across the end to end supply chain in order to drive the viability of sea freight?
  • What remains to be done and why is collaboration of huge importance?

Alan Kennedy

Director
Poseidon

Torben Weilmuenster, Head of Global Supply Chain Management at Merz Pharma

Torben Weilmuenster

Head of Global Supply Chain Management
Merz Pharma

Isabelle Conrot, Head of Global Supply Chain Operations at Roche

Isabelle Conrot

Head of Global Supply Chain Operations
Roche

10:20 am - 10:40 am CASE STUDY – How to improve on visibility, cost and feasibility of global sea freight operations in pharma

  • An update on groundbreaking activities being developed within sea freight operations for pharma
  • How are several key stakeholders working together in order to actualize these operations on a global scale?
  • What are the greatest ongoing challenges to the project and to industry wide adoption?
  • How are these challenges being overcome and what lessons have been learnt form the project?

10:40 am - 11:20 am KEYNOTE PRESENTATION – How to strategise for and implement data driven end to end supply chain operations on a global scale

  • What is meant by ‘data driven operations’ and what are the most significant benefits to the organisation?
  • What is required from top level management to embrace and implement and data driven operations?
  • Lessons learnt and best practice derived from at scale implementation from one of the largest producers in the world
Marc Molinaro, Head IT Supply Chain and Technical Operations Strategy at Novartis

Marc Molinaro

Head IT Supply Chain and Technical Operations Strategy
Novartis

11:20 am - 12:00 pm Morning networking break

11:20 am - 12:10 pm MASTERCLASS (50 mins)

11:20 am - 12:10 pm MASTERCLASS (50 mins)

TRACKS

TRACK A - Strengthening Not-For Profit and Emerging Market Opportunities

12:00 pm - 12:20 pm CASE STUDY – Update from The Global Fund: How is supply chain playing the pivotal role in the world’s fight against tuberculosis, AIDS and malaria?
Philippe Francois, VP Global Supply Chain at The Global Fund

Philippe Francois

VP Global Supply Chain
The Global Fund

TRACK A - Strengthening Not-For Profit and Emerging Market Opportunities

12:20 pm - 12:40 pm CASE STUDY - How to develop blockchain solutions from proof-of-concept through to at-scale use in pharma supply to tackle reproducibility, data sharing, traceability and privacy challenges

TRACK A - Strengthening Not-For Profit and Emerging Market Opportunities

12:40 pm - 1:00 pm CASE STUDY – What are the greatest GDP challenges that arose from vaccine distribution and supply chain activities during the ebola crisis, and how was these best managed?
Marco Gaudesi, Pharmacist & Head of GDP and Cold Chain at Médecins Sans Frontières

Marco Gaudesi

Pharmacist & Head of GDP and Cold Chain
Médecins Sans Frontières

TRACK A - Strengthening Not-For Profit and Emerging Market Opportunities

1:00 pm - 1:20 pm CASE STUDY - How can pharma producers of all sizes drive their not for profit activities through supply chain and achieve greater corporate social responsibility in the process?

TRACK B - Mastering Temperature Control & Logistics

12:00 pm - 12:40 pm CASE STUDY INTERACTIVE – How are temperature controlled logistics networks developing in step to meet the significant requirements cell gene therapies?

Roman Mijnhart

Senior Global Supply Chain Quality Director
Sanofi

Giane Olaes-Denis

Global Supply Chain Quality Manager
Sanofi

TRACK B - Mastering Temperature Control & Logistics

12:40 pm - 1:20 pm PANEL DISCUSSION – Exploiting multi-modal: How can you best deliver best practice network design for temperature controlled logistics on a global scale?
Bert Lemmens, Supply Chain Director EMEA at Terumo

Bert Lemmens

Supply Chain Director EMEA
Terumo

Tommy Jennings, Associate Director Global Logistics at Allergan

Tommy Jennings

Associate Director Global Logistics
Allergan

Robin Doppleb, Global Head of Logistics & Distribution at Vifor Pharma

Robin Doppleb

Global Head of Logistics & Distribution
Vifor Pharma

TRACK C – Interactive Workshop

12:00 pm - 1:20 pm COLLABORATIVE WORKING GROUP - Crossing the Chasm: How to develop a systematic approach for supply chain and logistics scale up
Stuart Scammell, Global Head of Supply Chain at Amicus

Stuart Scammell

Global Head of Supply Chain
Amicus

Joseph Berry, Director Supply Chain at Amicus

Joseph Berry

Director Supply Chain
Amicus

1:20 pm - 2:00 pm Networking Lunch

TRACKS

Track A - Catalysing Innovation In End To End Supply Chains

2:00 pm - 2:30 pm OXFORD STYLE DEBATE – FOR and AGAINST: Drones delivery in pharmaceutical logistics is no longer a fringe technology
FOR – The use of drones is a highly versatile technology that is a viable logistics tool for a range of pharma distribution activities
AGAINST – Drones are still in the hype phase, and with the exception of a small number of use cases should not be considered as a viable operational tool
Emre Gollu, Senior Supply Chain Manager at UCB Pharma

Emre Gollu

Senior Supply Chain Manager
UCB Pharma

Track A - Catalysing Innovation In End To End Supply Chains

2:30 pm - 3:10 pm PANEL DISCUSSION - How can the industry collaborate to drive diversity, inclusion in the pharma supply chain?
  • Incorporating the viewpoints of a range of key stakeholders in pharma supply chain
  • What initiatives are taking place within big pharma around diversity, inclusion and equal opportunity?
  • What effects can this have upon talent pool and business results?
  • What opportunities for collaboration across producers and other stakeholders exist that help to promote this?

Alvine Tremoulet

EU Head of Diversity & Inclusion
Pfizer

Debbie Francis

Supply Chain Lead
GSK

Track A - Catalysing Innovation In End To End Supply Chains

3:10 pm - 3:30 pm FIRESIDE CHAT – What has the industry learnt from planning and operations associated with the political and commercial instability of Brexit?
  • What has the impact of Brexit been upon a range of producers and how did they choose to try and mitigate the risks associated with Brexit?
  • What would key players in the industry have done differently, were they to be given the opportunity (drawing lessons learnt)?
  • What have producers learnt that they can apply to future situations (drawing best practice)?
  • What near future geo-political risks do you see to the global pharma supply chain and why?
Caroline Panah, Director Manufacturing & Supply Chain Strategy at GSK

Caroline Panah

Director Manufacturing & Supply Chain Strategy
GSK

Karin Javelle, Director Supply Chain Planning at Baxter

Karin Javelle

Director Supply Chain Planning
Baxter

Track B - Pharma Supply Chain Dragons Den

2:00 pm - 2:30 pm COLLABORATIVE WORKING GROUP - What is the future of direct to patient and eCommerce for pharma and what must you do now to remain relevant into the future?
Bernhard Baertschi, Head of Export & Operation Management at A.Vogel Group

Bernhard Baertschi

Head of Export & Operation Management
A.Vogel Group

Track B - Pharma Supply Chain Dragons Den

2:30 pm - 3:30 pm Examining the latest and greatest industry innovations - Which offer true added value and should be considered in your future supply chain transformation plans?
Join our dragons during this exciting ‘Dragons Den’ style session, where you will hear from four new and innovative start-up technology firms as they present their offerings in a bid to win first place. Listen up as the dragons’ review the technologies’ benefits to your business, predict their future success and deliver their verdicts. The ultimate decision is in your hands though, as the audience get to vote for their favorite.

3:30 pm - 3:45 pm End of LogiPharma 2020